Design of Brand Names of Medicines Considering Subjects’ Preferences.
In: Therapeutic Innovation & Regulatory Science, Jg. 52 (2018-03-01), Heft 2, S. 230-235
Online
academicJournal
Zugriff:
Background: Only recently, regulations on the names of medicines were developed. Regulations are mainly focused on avoiding the approval of medicine names that may be confusing to others. Furthermore, legal requirements do not include testing for human factors, such as potential users’ preferences. Study aims: To develop a set of new brand names of medicines, to determine subjects’ preferred names, and to evaluate if the linguistic features of these names were related to subjects’ preferences. Methods: Forty-six new names linguistically equivalent to the Portuguese brand names of medicines were developed. A panel of 13 postgraduates on linguistic studies were purposively enrolled. Participants were required to select and categorize the 6 most preferred names. Results: From the 29 selected names: 62.1% ended in consonants, 65.5% contained at least one syllable of the CVC type, and 62.1% presented final stress. Considering these 3 linguistic features, there were statistically significant differences between the preferred and underpreferred names: χ 2 = 4.572, P = .032; χ 2 = 5.599, P = .018; and χ 2 = 4.572; P = .032, respectively. Conclusions: Some linguistic features of the evaluated names were related to subjects’ preferences. Tests on subjects’ preferences about the names of medicines may provide additional safety features addressed by the present regulations. [ABSTRACT FROM AUTHOR]
Copyright of Therapeutic Innovation & Regulatory Science is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Design of Brand Names of Medicines Considering Subjects’ Preferences.
|
---|---|
Autor/in / Beteiligte Person: | Pires, Carla Maria Batista Ferreira ; Cavaco, Afonso |
Link: | |
Zeitschrift: | Therapeutic Innovation & Regulatory Science, Jg. 52 (2018-03-01), Heft 2, S. 230-235 |
Veröffentlichung: | 2018 |
Medientyp: | academicJournal |
ISSN: | 2168-4790 (print) |
DOI: | 10.1177/2168479017719933 |
Schlagwort: |
|
Sonstiges: |
|